U.S. vascular access devices market is experiencing a big transformation as healthcare providers increasingly favor cost-effective options with lower complication rates.
The market, valued at nearly $6 billion in 2024, is expected to grow to reach nearly $6.9 billion over the forecast period.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents:
➜ U.S. Vascular Access Devices Market Overview
➜ The Rise of Peripheral Alternatives
➜ U.S. Vascular Access Devices Innovation Trends
➜ U.S. Vascular Access Devices Emerging Market Technologies
➜ U.S. Vascular Access Devices Key Market Drivers
➜ U.S. Vascular Access Devices Future Market Outlook
➜ Get a Complimentary U.S. Vascular Access Devices Market Report Summary
Key Takeaways
- The U.S. vascular access devices market reached nearly $6 billion in 2024
- Market projected to grow at to nearly $6.9 billion
- Midlines and extended dwell catheters gaining popularity over PICCs
- Extended dwell catheters typically cost less than midlines while offering similar benefits
- Smart IV catheters with sensors are enhancing patient safety and clinical workflows
U.S. Vascular Access Devices Market Overview
The U.S. vascular access devices and accessories market demonstrates steady growth, reflecting the healthcare industry’s evolution toward safer, more cost-effective solutions.
The market’s progression from nearly $6 billion in 2024 to an expected $6.9 billion represents consistent demand driven by several key factors.
Healthcare providers are prioritizing vascular access options that deliver:
- Lower complication rates
- Reduced infection risks
- Cost-effectiveness
- Improved patient safety outcomes
The market shift indicates a change in clinical preferences, moving away from traditional central venous access methods toward peripheral alternatives.
The Rise of Peripheral Alternatives
Midline catheters were first introduced in the 1950s but fell out of favor due to reimbursement changes that shifted access procedures into acute care settings where PICCs became the primary choice.
The current resurgence of midlines is driven by several clinical developments:
Key changes include:
- New appropriate-use guidelines outlining when midlines are safer and more cost-effective than central lines.
- Clinical research supporting the safe administration of vancomycin through select midlines, previously considered off-limits for such medications.
- The removal of pH as a standalone indicator for central line placement, enabling wider adoption of peripheral access for drugs that were once thought to require central delivery.
These changes have positioned midlines as a safer, more practical alternative for many patients who don’t need full central venous access.
Safety Advantages:
- Shorter length compared to PICCs
- Insertion into peripheral rather than central veins
- Lower likelihood of infection due to peripheral placement
- Suitable alternative when longer dwelling time is required without central venous access
Extended Dwell Catheters: The Cost-Effective Solution
Extended dwell catheters are now the fastest-growing product category in the vascular access space.
These devices, typically used for intermediate durations (more than a few days but less than a month), are quickly becoming the go-to solution in a range of care settings from hospitals to outpatient clinics and home health.
Why They’re Gaining Ground
Cost-effectiveness is a major driver of adoption. Extended dwell catheters usually cost less than midlines and deliver many of the same clinical benefits.
This makes them especially appealing to facilities operating under tight budgets or seeking alternatives to more expensive central access options.
On the clinical side, they’re a preferred option when:
- Peripheral IV catheters (PIVCs) are insufficient due to short dwell times.
- PICCs are unnecessary or carry elevated risk for the patient.
- A reliable intermediate-term access device is required for therapies like IV antibiotics or hydration.
Much like midlines, extended dwell catheters are benefiting from new guidelines, infection control goals, and the growing focus on patient-centered care.
U.S. Vascular Access Devices Innovation Trends
Smart IV Catheters and Sensor-Driven Innovation
Smart IV catheters with built-in sensors are transforming vascular access by providing real-time data on infusion rates, pressure changes, and early signs of complications like infiltration.
This continuous monitoring enables faster clinical responses and better patient safety. These devices also reduce manual checks, improving workflow efficiency and minimizing errors.
Meanwhile, advancements in peripheral IV catheter (PIVC) materials and design, such as antimicrobial coatings and longer-lasting components, are enhancing dwell times and reducing failure and infection rates.
Together, these innovations are raising care standards in both hospital and outpatient environments.
U.S. Vascular Access Devices Emerging Market Technologies
Robotic and Minimally Invasive Access
Vascular access is becoming less invasive thanks to robotic-assisted PICC placement. These systems offer higher precision, lower infection risk, and less trauma, leading to faster recovery and shorter hospital stays.
Rise of Needle-Free Solutions
Needle-free devices use pressure or fluid jets to access veins without traditional needles. They’re safer, reduce contamination risks, and are especially useful for children, seniors, and anxious patients. Hospitals and home-care providers are adopting them quickly.
Telemedicine Integration
Remote monitoring now lets clinicians track IV status and catch early complications like infection or thrombosis, without in-person visits. It’s a game changer for rural care and overloaded hospitals, improving both outcomes and efficiency.
Bioactive Coatings for Safer Use
Catheters with antimicrobial or anti-clot coatings help prevent infections and reduce device failure. These coatings are especially important for long-term users, improving safety while cutting the need for replacements.
U.S. Vascular Access Devices Key Market Drivers
Catheter securement devices are essential for reducing complications from line movement. Their growing use, especially for peripheral IV catheters (PIVCs), is helping drive expansion across the vascular access market.
While they add modest costs to procedures, securement solutions are increasingly seen as critical to clinical outcomes.
Complementary accessories like disinfecting caps and antimicrobial patches are also gaining ground.
Hospitals adopt them widely for their proven ability to reduce catheter-related bloodstream infections and cut treatment costs.
What’s driving demand:
- Disinfecting caps that kill microbes inside catheters
- Antimicrobial patches protecting insertion sites
- Strong clinical proof + economic benefits in high-volume settings
Meanwhile, midline and extended dwell catheters are rebounding thanks to new guidelines and research.
With vancomycin now considered safe for select midlines and less emphasis on pH for line placement, clinicians are shifting back to these cost-effective alternatives, setting the stage for sustained growth.
U.S. Vascular Access Devices Future Market Outlook
The U.S. vascular access devices market is positioned for sustained growth driven by several key trends:
Technology Integration:
- Continued development of smart IV catheters with enhanced monitoring capabilities
- Expansion of needle-free access solutions
- Growing integration of telemedicine and remote monitoring platforms
Clinical Practice Evolution:
- Ongoing shift toward peripheral alternatives to central venous access
- Increased adoption of minimally invasive techniques
- Greater emphasis on infection prevention through bioactive coatings
Market Opportunities:
- Extended dwell catheters representing fastest-growing segment
- Catheter securement devices showing consistent growth potential
- Antimicrobial accessories demonstrating strong market expansion
Cost-Effectiveness Focus: Healthcare systems will continue prioritizing solutions that deliver clinical benefits while managing costs, driving demand for devices like extended dwell catheters that offer midline benefits at lower price points.
The market’s evolution reflects healthcare’s commitment to improving patient outcomes while optimizing resource utilization, positioning the vascular access devices sector for continued growth and innovation.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
